Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $1.91 billion. The enterprise value is $1.66 billion.

Market Cap	1.91B
Enterprise Value	1.66B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

SLNO has 43.12 million shares outstanding. The number of shares has increased by 271.22% in one year.

Current Share Class	43.12M
Shares Outstanding	43.12M
Shares Change (YoY)	+271.22%
Shares Change (QoQ)	+8.41%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	65.01%
Float	27.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.01
P/TBV Ratio	7.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.26, with a Debt / Equity ratio of 0.01.

Current Ratio	17.26
Quick Ratio	17.16
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.11% and return on invested capital (ROIC) is -59.39%.

Return on Equity (ROE)	-91.11%
Return on Assets (ROA)	-48.05%
Return on Capital (ROIC)	-59.39%
Revenue Per Employee	n/a
Profits Per Employee	-$3.97M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.51% in the last 52 weeks. The beta is -1.53, so SLNO's price volatility has been lower than the market average.

Beta (5Y)	-1.53
52-Week Price Change	+17.51%
50-Day Moving Average	52.69
200-Day Moving Average	47.13
Relative Strength Index (RSI)	30.56
Average Volume (20 Days)	763,984

Short Selling Information

The latest short interest is 4.56 million, so 10.57% of the outstanding shares have been sold short.

Short Interest	4.56M
Short Previous Month	4.74M
Short % of Shares Out	10.57%
Short % of Float	16.33%
Short Ratio (days to cover)	7.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-138.47M
Pretax Income	-65.41M
Net Income	-131.16M
EBITDA	-136.50M
EBIT	-138.47M
Earnings Per Share (EPS)	-$3.47

Full Income Statement

Balance Sheet

The company has $256.78 million in cash and $3.03 million in debt, giving a net cash position of $281.69 million or $6.53 per share.

Cash & Cash Equivalents	256.78M
Total Debt	3.03M
Net Cash	281.69M
Net Cash Per Share	$6.53
Equity (Book Value)	264.70M
Book Value Per Share	6.45
Working Capital	243.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.42 million and capital expenditures -$210,000, giving a free cash flow of -$51.63 million.

Operating Cash Flow	-51.42M
Capital Expenditures	-210,000
Free Cash Flow	-51.63M
FCF Per Share	-$1.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-271.22%
Shareholder Yield	-271.22%
Earnings Yield	-6.74%
FCF Yield	-2.65%

Analyst Forecast

The average price target for SLNO is $74.83, which is 68.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$74.83
Price Target Difference	68.88%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 26, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2